Zomedica Unveils Equine Asthma Clinical Registry

Zomedica Corp., a veterinary health company, has launched the Equine Asthma Clinical Registry, an initiative aimed at addressing asthma in horses using PulseVet® shock wave therapy. This approach offers a non-invasive and drug-free alternative for asthma treatment in horses, a condition affecting approximately 15% of horses over seven years old.

The registry seeks to gather clinical data to improve treatment strategies. Studies indicate that the PulseVet system's electrohydraulic extracorporeal shock wave therapy (ESWT) significantly enhances respiratory health in affected horses, with 58 horses having completed treatment without adverse effects.

Dr. Beau Whitaker from Brazos Valley Equine Hospital noted improvements in clinical signs following ESWT treatment. Clinics can enroll up to 20 horses, aiding research while gaining product credits. This registry underscores Zomedica's commitment to advancing veterinary care through evidence-based solutions.